We have observed
10 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 publication dated after
January 19, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
COMPOSITION COMPRISING ANGIOTENSIN II RECEPTOR ANTAGONIST AND ANTIOXIDANT FOR MAINTAINING AND/OR IMPROVING SKIN PROPERTIES
TREATMENT OF ARTERIAL AGEING BY COMBINATION OF RAAS INHIBITOR AND HMG-CoA REDUCTASE INHIBITOR
TREATMENT OF ARTERIAL AGEING BY RAAS INHIBITOR
TREATMENT OF ARTERIAL WALL BY COMBINATION OF RAAS INHIBITOR AND HMG-CoA REDUCTASE INHIBITOR
METHODS FOR USING SEMAPHORIN POLYPEPTIDES
Filter system for cabins
HARNESS FOR THORACIC SUPPORT WITH DOUBLE ACTION (IMMOBILIZATION AND SUPPORT)
Power transmission system
RELATIVE EXCITATION FEATURES FOR SPEECH RECOGNITION
HOLDING DEVICE FOR HOLDING A SHIP'S BOAT OR OTHER ADDITIONAL COMPONENT TO BE CARRIED ALONG, AND USE OF SAID DEVICE